Home/Vetoquinol/Matthieu Frechin

MF

Matthieu Frechin

Chief Executive Officer (CEO)

Therapeutic Areas

Companion Animal Health Livestock Health

Vetoquinol Pipeline

Drug	Indication	Phase
Zeleris (fezolinetant vet. analog)	Canine Atopic Dermatitis	Phase III / Registration
Novel Zinc Oxide Alternative	Post-weaning Diarrhea in Piglets	Development
Long-acting Injectable Portfolio	Parasiticides & Antibiotics for Livestock	Ongoing Development

Leadership Team at Vetoquinol

Jean-Luc Dassonville

Deputy Chief Executive Officer, Operations

Stéphane Le Henaff

Chief Financial Officer (CFO)

Dr. Pierre R. Condé

Chief Scientific Officer (CSO)

Chairman of the Board

View full Vetoquinol profile